Mark Till

Phase I immunotoxin trial in patients with B-cell lymphoma.

E S Vitetta, Marvin J. Stone, P L Amlot et al. · PubMed · 1991 · 286 citations

Immunodeficiencies, Immunology, Immunoediting +19

HIV-Infected Cells Are Killed by rCD4-Ricin A Chain

Mark Till, Victor Gheţie, Timothy J. Gregory et al. · Science · 1988 · 142 citations

Cell Surface Cd4, Immunology, Antiviral Drug +16

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

Maria‐Ana Ghetie, Richard May, Mark Till et al. · PubMed · 1988 · 118 citations

Immunology, Immunoediting, Pathology +22

Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the <i>in vivo</i> therapy of human B‐cell leukemias and lymphomas

Guo‐Liang Shen, Jialing Li, Maria‐Ana Ghetie et al. · International Journal of Cancer · 1988 · 71 citations

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

Mark Till, Susan Zolla‐Pazner, Miroslaw K. Górny et al. · Proceedings of the National Academy of Sciences · 1989 · 62 citations · Full text

Primary Immunodeficiency, Human Immunodeficiency Virus, Autoimmune Disease +15